
The Keystone Symposia conference, “Cancer Immunotherapy: Basic Mechanisms Informing Clinical Applications and Combinations,” will be held from March 15–18, 2026, at the Fairmont Le Château Frontenac in Québec City, Québec, Canada.
This meeting brings together leading experts from academia, industry, and clinical medicine to examine the limitations of current immunotherapies and the mechanisms of resistance, with the goal of guiding strategies to overcome these hurdles and improve clinical outcomes; the sessions will highlight emerging research on targeting stromal and myeloid cells, tumor recognition, and advanced technologies like spatial imaging and AI.